Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... patients with type 2 diabetes) under microbial lipopolysaccharide (LPS) with IL-6 and rosiglitazone treatment. We also tested the lactoferrin action in THP-1 cells under LPS stimulus. ...
2009 NOV 23 ... in plasma glucose and insulin level. Interestingly, 18179 was as efficacious as rosiglitazone but did not cause body weight gain and hepatic adverse effects. In addition, 18F9 ...
2009 NOV 2 ... a constant challenge for healthcare providers and patients alike." "Rosiglitazone maleate + metformin hydrochloride extend is a new compound that has the advantage of the ...
2009 NOV 1 ... vein grafts leads to graft failure in approximately 50% of cases over a 10-year period. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, has been shown to improve ...
2009 NOV 9 ... agonists are conflicting. On one hand, it was suggested that the PPAR-gamma agonist rosiglitazone may increase the risk of cardiovascular events," scientists writing in the journal ...
2009 NOV 16 ... human and murine adipocytes as well as in vivo in epididymal fat pads of mice upon rosiglitazone stimulation, whereas small interfering RNA-mediated knockdown of PPAR gamma in ...
2009 NOV 1 ... randomized 1:1:1 to instead receive repaglinide/metformin FDC either BID or TID or a rosiglitazone/metformin FDC BID." "Two primary hypotheses were tested in a hierarchical ...
2009 NOV 2 ... sample groups; the sample groups received BNR17 (10(7), 108, 10(9) and 10(10) CFU) or rosiglitazone (8 mg kg(-1)) orally twice a day for 12 weeks." "BNR17 groups had a ...
2009 NOV 1 ... pathway is involved in high glucose-induced endothelial cell apoptosis and rosiglitazone has a protective effect on endothelium. In the present study, we investigated the ...
2009 NOV 23 ... ovarian syndrome (PCOS) and recent studies have shown that thiazolidinediones such as rosiglitazone improve fertility in women with PCOS but the mechanism is not well defined." ...
2009 NOV 16 ... stress in RVLM. In Sprague-Dawley rats, transcriptional upregulation of UCP2 in RVLM by rosiglitazone, an activator of its transcription factor peroxisome proliferator-activated receptor ...
2009 NOV 2 ... a likely contributor. We aimed to assess noninvasively the efficacy of metformin and rosiglitazone monotherapy in normalizing myocardial substrate metabolism in an animal model of type 2 ...
2009 NOV 9 ... to recent research from the United States, "Published studies of patients treated with rosiglitazone or pioglitazone have reported greater reductions in HbA1c (A1C) than studies of ...
2009 NOV 16 ... control subjects. Furthermore, we examined the effect of 8 wk of insulin sensitizing by rosiglitazone on muscle OXPAT and ADRP content. OXPAT and ADRP protein expression is muscle fiber type ...
2009 NOV 9 ... a study "To investigate the relationship between osteoporotic vertebral fractures and rosiglitazone treatment and the influence on this association of bone mineral density (BMD) and ...
2009 NOV 2 ... According to a study from the United States, "Rosiglitazone is a peroxisome proliferator-activated receptor (PPAR) gamma agonist that has shown ...
2009 NOV 9 ... is a major cause of chemotherapy failure in advanced hepatocellular carcinoma (HCC). Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist, has a crucial ...
2009 NOV 23 ... results of clinical trials have suggested that the thiazolidinedione antidiabetic agents rosiglitazone and pioglitazone are associated with an increased risk of fractures, but such studies ...
2009 NOV 9 ... uniflorum, was discovered as a novel PPAR gamma antagonist capable of inhibiting rosiglitazone-induced PPAR gamma transcriptional activity. SPR analysis suggested that CAB bound ...
